Minowa, T <br/><br/>
Increase in tumour permeability following TGF-beta type I receptor-inhibitor treatment observed by dynamic contrast-enhanced MRI.  [electronic resource] 

 -  British journal of cancer  Dec 2009 
 - 1884-90 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6605367  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Capillary Permeability--drug effects<br/>Cell Growth Processes--drug effects<br/>Cell Line, Tumor<br/>Contrast Media<br/>Diffusion Magnetic Resonance Imaging--methods<br/>Endothelial Cells--drug effects<br/>Female<br/>Gadolinium DTPA--pharmacokinetics<br/>Humans<br/>Mice<br/>Neoplasms, Experimental--blood supply<br/>Neovascularization, Pathologic--drug therapy<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Pyrazoles--pharmacology<br/>Receptor, Transforming Growth Factor-beta Type I<br/>Receptors, Transforming Growth Factor beta--antagonists & inhibitors<br/>Thiocarbamates--pharmacology<br/>Thiosemicarbazones